Evidence map›Paper›PMID 38594380›Full record

ArticleCommunications biology2024

Vaccine-elicited IL-1R signaling results in Th17 TRM-mediated immunity.

Joseph P Hoffmann, Akhilesh Srivastava, Haoran Yang, Naoki Iwanaga, T Parks Remcho, Jenny L Hewes, Rayshma Sharoff, Kejing Song, Elizabeth B Norton, Jay K Kolls and 1 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Joseph P HoffmannCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.ORCID 0000-0001-8300-7782
Akhilesh SrivastavaCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.
Haoran YangCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.ORCID 0000-0002-6464-8450
Naoki IwanagaCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.ORCID 0000-0002-0680-390X
T Parks RemchoCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.
Jenny L HewesCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.
Rayshma SharoffCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.
Kejing SongCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.
Elizabeth B NortonDepartment of Immunology and Microbiology, Tulane University School of Medicine, New Orleans, LA, USA.
Jay K KollsCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA.ORCID 0000-0001-5151-6304
Janet E McCombsCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, LA, USA. jmccombs@tulane.edu.ORCID 0000-0002-3514-8019
Tulane University · US

Funding

Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
Evaluation of Memory Responses and Biomarkers from a Phase IEnterotoxigenic Escherichia coli (ETEC) Intramuscular SubunitVaccine with dmLT AdjuvantR01AI166682 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI NORTON, ELIZABETH B · 2021 to 2025
$3.5M
Development of Novel Adjuvants LTA and LTA1R01AI114697 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI NORTON, ELIZABETH B · 2015 to 2019
$2.1M
Immunotherapy of KPC InfectionR01AI149119 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2020 to 2023
$1.9M
NHLBI NIH HHS R35 HL139930NIAID NIH HHS R01 AI114697NIAID NIH HHS R01 AI149119NIAID NIH HHS R01 AI166682
6 · The paper itself

Abstract

Lung tissue resident memory (TRM) cells are thought to play crucial roles in lung host defense. We have recently shown that immunization with the adjuvant LTA1 (derived from the A1 domain of E. coli heat labile toxin) admixed with OmpX from K. pneumoniae can elicit antigen specific lung Th17 TRM cells that provide serotype independent immunity to members of the Enterobacteriaceae family. However, the upstream requirements to generate these cells are unclear. Single-cell RNA-seq showed that vaccine-elicited Th17 TRM cells expressed high levels of IL-1R1, suggesting that IL-1 family members may be critical to generate these cells. Using a combination of genetic and antibody neutralization approaches, we show that Th17 TRM cells can be generated independent of caspase-1 but are compromised when IL-1α is neutralized. Moreover IL-1α could serve as a molecular adjuvant to generate lung Th17 TRM cells independent of LTA1. Taken together, these data suggest that IL-1α plays a major role in vaccine-mediated lung Th17 TRM generation.

Indexed as

Escherichia coliVaccinesAdjuvants, ImmunologicImmunizationImmunologic MemoryAdjuvants, ImmunologicVaccines

Identifiers

PMID38594380
PMCPMC11003962
OpenAlexW4394596423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.